MacroGenics preclinical data

In a mouse xenograft model of pharyngeal carcinoma, MGD009 led to regression of B7-H3 ( CD276)-expressing tumors. The bispecific antibody against CD3 and CD276 developed using Dual-Affinity Re-Target...